共 103 条
[2]
A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): final results from the T- cell consortium trial
[J].
BRITISH JOURNAL OF HAEMATOLOGY,
2016, 172 (04)
:535-544
[5]
[Anonymous], BLOOD S1
[7]
ASHWORTH J, 1989, BRIT J DERMATOL, V120, P563